nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: A three-month, multicenter, randomized, double-masked, parallel-group trial
|
DuBiner, Harvey B |
|
2001 |
23 |
12 |
p. 1969-1983 15 p. |
artikel |
2 |
Author index
|
|
|
2001 |
23 |
12 |
p. 2056-2060 5 p. |
artikel |
3 |
Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections
|
Allin, Dennis |
|
2001 |
23 |
12 |
p. 1958-1968 11 p. |
artikel |
4 |
Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective
|
O'Brien, Bernie J. |
|
2001 |
23 |
12 |
p. 2038-2049 12 p. |
artikel |
5 |
Dear Dr. Walson
|
Subbiah, Ponni |
|
2001 |
23 |
12 |
p. 2050-2052 3 p. |
artikel |
6 |
Direct-to-consumer advertising: The jury is still out
|
Coons, Stephen Joel |
|
2001 |
23 |
12 |
p. 2022-2023 2 p. |
artikel |
7 |
Editorial comment
|
Walson, Philip D |
|
2001 |
23 |
12 |
p. 1923- 1 p. |
artikel |
8 |
Four-year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other antihypertensive drug classes
|
Conlin, Paul R. |
|
2001 |
23 |
12 |
p. 1999-2010 12 p. |
artikel |
9 |
Insulin glargine
|
Campbell, R.Keith |
|
2001 |
23 |
12 |
p. 1938-1957 20 p. |
artikel |
10 |
Patient autonomy and the regulation of direct-to-consumer advertising
|
Zachry III, Woodie M. |
|
2001 |
23 |
12 |
p. 2024-2037 14 p. |
artikel |
11 |
Response
|
Côté, Christine |
|
2001 |
23 |
12 |
p. 2052-2055 4 p. |
artikel |
12 |
Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin
|
Guay, David R.P. |
|
2001 |
23 |
12 |
p. 1924-1937 14 p. |
artikel |
13 |
Subject index
|
|
|
2001 |
23 |
12 |
p. 2061-2073 13 p. |
artikel |
14 |
Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2—selective inhibitors: analysis of a large United States claims database
|
Schnitzer, Thomas J. |
|
2001 |
23 |
12 |
p. 1984-1998 15 p. |
artikel |
15 |
Variability in the assessment of adverse events in a multicenter clinical trial
|
Raisch, Dennis W. |
|
2001 |
23 |
12 |
p. 2011-2020 10 p. |
artikel |